最新报道:WindTree Therapeutics, a biopharmaceutical company, has announced a strategic shift to incorporate Binance Coin (BNB) into its financial operations. The firm plans to use BNB for various corporate activities, including potential investments and treasury management, citing the cryptocurrency's stability and growing utility. This move aligns with WindTree's broader strategy to explore innovative financial technologies and digital asset integration. The company emphasized that adopting BNB could enhance operational efficiency and provide new avenues for capital deployment. Industry observers note this as a significant step in bridging traditional biopharma with blockchain-based financial solutions.